These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38105364)

  • 1. Use of Artificial Intelligence to Improve the Calculation of Percent Adhesion for Transdermal and Topical Delivery Systems.
    Wang C; Strasinger C; Weng YT; Zhao X
    J Med Syst; 2023 Dec; 48(1):4. PubMed ID: 38105364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical Considerations in Assessing In Vivo Adhesion with Transdermal and Topical Delivery Systems for New Drug Applications.
    Wang C; Strasinger C; Shen M; Tsong Y
    AAPS J; 2020 Oct; 22(6):137. PubMed ID: 33099695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical considerations and impact of the FDA draft guidance for assessing adhesion with transdermal delivery systems and topical patches for ANDAs.
    Sun W; Grosser S; Kim C; Raney SG
    J Biopharm Stat; 2019; 29(5):952-970. PubMed ID: 31495266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
    Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF
    Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the Road to Development of an in Vitro Permeation Test (IVPT) Model to Compare Heat Effects on Transdermal Delivery Systems: Exploratory Studies with Nicotine and Fentanyl.
    Shin SH; Ghosh P; Newman B; Hammell DC; Raney SG; Hassan HE; Stinchcomb AL
    Pharm Res; 2017 Sep; 34(9):1817-1830. PubMed ID: 28608140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of in vitro/in vivo correlations for three fentanyl transdermal delivery systems using in vitro skin permeation testing and human pharmacokinetic studies under the influence of transient heat application.
    Shin SH; Yu M; Hammell DC; Ghosh P; Raney SG; Hassan HE; Stinchcomb AL
    J Control Release; 2022 Feb; 342():134-147. PubMed ID: 34838928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of the Rate and Extent of Drug Released from Commercial Topical Delivery Systems During Wear: An Example with Lidocaine Topical Systems.
    Cai Q; Azarpanah A; Bhatt JA; Wei H; Carr J; Morris KR; Strasinger C; Brogden NK
    Pharm Res; 2024 Jan; 41(1):39-50. PubMed ID: 37848751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug recrystallization in drug-in-adhesive transdermal delivery system: A case study of deteriorating the mechanical and rheological characteristics of testosterone TDS.
    Mohamed LA; Kamal N; Elfakhri KH; Willett D; Wokovich A; Strasinger C; Cruz CN; Raney SG; Ashraf M; Zidan AS
    Int J Pharm; 2020 Mar; 578():119132. PubMed ID: 32057892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative Methods to Animal Studies for the Evaluation of Topical/ Transdermal Drug Delivery Systems.
    Garcia MTJ; de Vasconcellos FLL; Raffier CP; Roberts MS; Grice JE; Benson HAE; Leite-Silva VR
    Curr Top Med Chem; 2018; 18(4):287-299. PubMed ID: 29651933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of a new testosterone transdermal delivery system, TDS-testosterone in healthy males.
    Chik Z; Johnston A; Tucker AT; Chew SL; Michaels L; Alam CA
    Br J Clin Pharmacol; 2006 Mar; 61(3):275-9. PubMed ID: 16487220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat effects on drug delivery across human skin.
    Hao J; Ghosh P; Li SK; Newman B; Kasting GB; Raney SG
    Expert Opin Drug Deliv; 2016; 13(5):755-68. PubMed ID: 26808472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of a drug-in-adhesive transdermal delivery system for delivery of olanzapine.
    Vora D; Banga AK
    Expert Opin Drug Deliv; 2022 Nov; 19(11):1539-1548. PubMed ID: 36242524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of residual solvents on the physical properties of transdermal drug delivery systems.
    Mazumder S; Shakleya D; Mattson S; Ashraf M; Faustino P; Pavurala N
    Int J Pharm; 2020 Oct; 588():119713. PubMed ID: 32755689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How physical techniques improve the transdermal permeation of therapeutics: A review.
    Gao Y; Du L; Li Q; Li Q; Zhu L; Yang M; Wang X; Zhao B; Ma S
    Medicine (Baltimore); 2022 Jul; 101(26):e29314. PubMed ID: 35777055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro-in vivo correlations for nicotine transdermal delivery systems evaluated by both in vitro skin permeation (IVPT) and in vivo serum pharmacokinetics under the influence of transient heat application.
    Shin SH; Thomas S; Raney SG; Ghosh P; Hammell DC; El-Kamary SS; Chen WH; Billington MM; Hassan HE; Stinchcomb AL
    J Control Release; 2018 Jan; 270():76-88. PubMed ID: 29175139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D printing applications for transdermal drug delivery.
    Economidou SN; Lamprou DA; Douroumis D
    Int J Pharm; 2018 Jun; 544(2):415-424. PubMed ID: 29355656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic delivery systems: a new approach to evaluate physical properties of transdermal delivery systems (TDS).
    Ehrlich A; Henkel-Ernst J; Schaefer A; Assmussen B; Lücker PW
    Methods Find Exp Clin Pharmacol; 1999; 21(1):69-71. PubMed ID: 10222451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Navigating sticky areas in transdermal product development.
    Strasinger C; Raney SG; Tran DC; Ghosh P; Newman B; Bashaw ED; Ghosh T; Shukla CG
    J Control Release; 2016 Jul; 233():1-9. PubMed ID: 27117457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems.
    Lee KE; Choi YJ; Oh BR; Chun IK; Gwak HS
    Int J Pharm; 2013 Nov; 456(2):432-6. PubMed ID: 24008082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new transdermal delivery system for pilocarpine in glaucoma treatment.
    Dinslage S; Diestelhorst M; Hille T; Otto K
    Ger J Ophthalmol; 1996 Sep; 5(5):275-80. PubMed ID: 8911949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.